| Home Forums |
|
|||||||
| MDS Myelodysplastic syndromes |
 |
|
|
Thread Tools | Search this Thread |
|
#1
Fri Aug 30, 2013, 10:01 PM
|
|||
|
|||
|
Campath retrospective...lower-risk MDS
There is a new discussion today in the MDS Beacon regarding a recent small retrospective study by German researchers suggesting that a short course of treatment with the immunosuppressive agent, Campath, may be effective and safe for some patients with lower-risk MDS.
 http://www.mdsbeacon.com/news/2013/0...tic-syndromes/
__________________
Ric: Low-risk MDS (blasts <4%); 4 cycles Revlimid no positive response; PRBC transfusion dependent; so far, 392'units' over 8 3/4 years; BMB #4 (15/04/01) shows evolution to AML (blasts 20-30%  ) 47,XY,del(5) (q22q35),+21[24][cp24]/46,XY(1).
|
|
| Thread Tools | Search this Thread |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| MDS - VA assigns diagnostic code 7725 | Tommy Daniels | MDS | 4 | Sun Jan 22, 2017 04:51 PM |
| Under 60 and Have Low Risk MDS? Read this. | Greg H | Drugs and Drug Treatments | 5 | Sun Sep 18, 2011 03:58 PM |
| The lower risk MDS patient at risk of rapid progression | akita | MDS | 0 | Mon Dec 27, 2010 05:28 AM |
| Alemtuzumab (Campath) Effective in MDS | BarryB | Drugs and Drug Treatments | 3 | Sun Dec 13, 2009 10:32 AM |
